Milestone Pharmaceuticals Inc. — Director's Dealing 2021

Jul 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2021-06-14

Reporting Person: Wills Robert James (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-14	Stock Option (right to buy)	$5.54	A	30000	Acquired	2031-06-14	Common Shares (30000)	Direct

Footnotes

F1: This option will vest in twelve (12) equal monthly installments, beginning on July 14, 2021, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.